Menu
COVID-19: Second dose trial of Covaxin on 2-6 years to begin...
New Delhi [India], July 23 (ANI): As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely...
'Submit results on Covavax adult trials first': Govt panel to...
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting...
Johnson & Johnson won't be conducting COVID-19 vaccine...
New Delhi [India], June 29 (ANI): Johnson & Johnson will not be conducting local trials in India for its...
AIIMS Delhi to start Covaxin trials on children in few days,...
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is...
Israel to start phase 2 of COVID-19 vaccine trials in coming...
Tel Aviv [Israel], December 15 (ANI/Sputnik): The Israel Institute for Biological Research (IIBR) has successfully...
MP Home Minister ready to volunteer for COVID-19 vaccine trial
Bhopal (Madhya Pradesh) [India], December 4 (ANI): Madhya Pradesh Home Minister Narottam Mishra on Thursday said he...
`Adverse event' has not affected timelines of COVID-19...
New Delhi [India], December 2 (ANI): Health Secretary Rajesh Bhushan said on Tuesday that "adverse event" related...
Pfizer says Covid-19 vaccine trial complete, cites shot is 95...
Washington [US], November 18 (ANI): American drug giant Pfizer on Wednesday said that final results from the...
China's COVID-19 vaccine trials suspended in Brazil after...
Brasilia [Brazil], November 10 (ANI): Brazil's health regulator Anvisa said on Monday it has suspended clinical...
AstraZeneca resumes US COVID-19 vaccine trial
London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have...
Equity indices shed early losses, financials and banking...
Mumbai (Maharashtra) [India], Oct 14 (ANI): Equity benchmark indices witnessed a sharp recovery in the last hour of...
Equity indices tumble amid weak global cues, banking and IT...
Mumbai (Maharashtra) [India], October 14 (ANI): Equity benchmark indices tumbled over half per cent during early...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.